Shuttle Pharmaceuticals Announces Private Placement of $4.3 Million of Senior Secured Convertible Note and Warrants
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) announced a private placement of a $4.3 million senior secured convertible note and warrant. The company will receive $4.0 million initially, with a potential for an additional $2.4 million if warrants are exercised at $2.35 per share. Monthly amortizations can be settled in cash or stock and the deal has a 5% annual interest rate.
This initiative aims to support Shuttle's mission to enhance cancer treatment outcomes while minimizing radiation side effects.
Positive
- Successfully secured $4.3 million in funding through a senior secured convertible note and warrant.
- Initial gross proceeds of $4.0 million bolster the company's financial position.
- Potential for an additional $2.4 million from warrant exercises strengthens future capital.
- Interest rate of 5% per annum is favorable for the company.
Negative
- None.
Details
News Market Reaction – SHPH
The recorded move for SHPH in the trading session of this news was +32.20%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The note amortizes on a monthly basis and
About
Founded in 2012 by faculty members of the
Safe Harbor Statement
Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the "Risk Factors" section of the IPO prospectus filed with the
For more information, please contact:
240-403-4212
info@shuttlepharma.com
Investors
602-889-9700
SHPH@lythampartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shuttle-pharmaceuticals-announces-private-placement-of-4-3-million-of-senior-secured-convertible-note-and-warrants-301720779.html
SOURCE
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.